Santiago Grau Cerrato

Department of Pharmacology, Therapeutics and Toxicology

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Ph. D., Universitat de Barcelona

Award Date: 25 May 1995

Fingerprint

Dive into the research topics where Santiago Grau Cerrato is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

9 Similar Profiles

1611 Citations
23 h-Index
141 Article
9 Review article
3 Chapter
1 Book

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
Ruiz-Antorán, B., Sancho-López, A., Torres, F., Moreno-Torres, V., de Pablo-López, I., García-López, P., Abad-Santos, F., Rosso-Fernández, C. M., Aldea-Perona, A., Montané, E., Aparicio-Hernández, R. M., Llop-Rius, R., Pedrós, C., Gijón, P., Hernández-Carballo, C., Pedrosa-Martínez, M. J., Rodríguez-Jiménez, C., Prada-Ramallal, G., Cabrera-García, L., Aguilar-García, J. A. & 71 others, Sanjuan-Jimenez, R., Ortiz-Barraza, E. I., Sánchez-Chica, E., Fernández-Cruz, A., Sala, X. F., Pellicer, P. D., Cerrato, S. G., Anillo, J. M. D., Palacios, A. R., Cubiles, E., Acosta, M. Á. L., Gutierrez, R. F., Candón, A. M., Alejandre, S. S., Herreros, J. M. C., Matía, E. C., Dominguez, C. I., Rivas, J. C. C., Verdugo, M. L., Toste, I. S., Pérez, P. D., Villero, F. M., Cuartin, G. S., Gonzalez, C. G., Fuster, A. I., Galmes, M. G., Pérez, S., Cumplido, D. R., de León Gil, A., Sanz, E. J., Sanz-Herrero, F., Puchades, F., Ortega-García, P., Díaz-Peromingo, J. A., Rodríguez-Moreno, C., Lozano, D., Terleira, A., Castro, M. E. G., Murcia, S. F., Aguilera, E. M. G., Pintos-Sanchez, E., Zubiaur, P., Santos-Molina, E., Navares-Gómez, M., Abril, G. M., García-Luque, A., Puerro-Vicente, M., Carrillo, M. J. S., Múgica, M. Á. G., Jiménez, M. A., Díaz, C. S., Solá, C. A., Mills-Sánchez, P., Valle, M., Centeno, G., Payares, C., Bermejo, A. F. C., Diago, E., de Molina, R. M., Nuñez, J. A. V., Muñez, E., Ramos, A., Barriocanal, A. M., Pérez-Acevedoc, A. P., Núñez-Montero, M., Olmedo, M., De la Villa, S., Álvarez, E. N., Lucena, M. I., García, J. A. A. & Alegría, J. J. G., 2020, In : Infectious Diseases and Therapy.
Research output: Contribution to journal › Article › Research › peer-review
Analysis of drug-related problems in a tertiary university hospital in Barcelona (Spain)
Ferrández, O., Casañ, B., Grau, S., Louro, J., Salas, E., Castells, X. & Sala, M., 1 Jul 2019, In : Gaceta Sanitaria. 33, p. 361-368
Research output: Contribution to journal › Article › Research
3 Citations (Scopus)
Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical
Sorlí, L., Luque, S., Li, J., Campillo, N., Danés, M., Montero, M., Segura, C., Grau, S. & Horcajada, J. P., 1 Sep 2019, In : Journal of Infection. 79, p. 253-261
Research output: Contribution to journal › Article › Research
8 Citations (Scopus)
Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones
Montero, M. M., Domene Ochoa, S., López-Causapé, C., VanScoy, B., Luque, S., Sorlí, L., Campillo, N., Padilla, E., Prim, N., Segura, C., Pomar, V., Rivera, A., Grau, S., Ambrose, P. G., Oliver, A. & Horcajada, J. P., 1 Sep 2019, In : Journal of Global Antimicrobial Resistance. 18, p. 37-44
Research output: Contribution to journal › Article › Research
5 Citations (Scopus)
Colistin use in patients with chronic kidney disease: Are we underdosing patients?
Sorli, L., Luque, S., Li, J., Rodríguez, E., Campillo, N., Fernandez, X., Soldado, J., Domingo, I., Montero, M., Grau, S. & Horcajada, J. P., 1 Feb 2019, In : Molecules. 24, 530.
Research output: Contribution to journal › Article › Research
2 Citations (Scopus)

Education/Academic qualification

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Analysis of drug-related problems in a tertiary university hospital in Barcelona (Spain)

Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical

Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones

Colistin use in patients with chronic kidney disease: Are we underdosing patients?